SCHEMBL30830692

SCHEMBL30830692

Cc1c(N[C@@H]2C[C@H](c3ccc(C(=O)N4CCC5(CCC(c6ccc(C7CCC(=O)NC7=O)cc6)CC5)CC4)cc3)CN(C)C2)ccn(C)c1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 6/20 0.33
▸ CRBN Q96SW2 6/20 0.33
▸ SETDB1 Q15047 1/20 0.32
▸ KAT2B Q92831 7/20 0.32
▸ BRD9 Q9H8M2 3/20 0.32
▸ BRD1 O95696 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ BRPF1 P55201 1/20 0.32
▸ BPTF Q12830 1/20 0.32
▸ KAT2A Q92830 1/20 0.32
▸ BRD7 Q9NPI1 1/20 0.32
▸ BAZ2B Q9UIF8 1/20 0.32
▸ BRPF3 Q9ULD4 1/20 0.32
▸ GABRD O14764 1/20 0.32
▸ GABRA1 P14867 1/20 0.32
▸ GABRB1 P18505 1/20 0.32
▸ GABRA5 P31644 1/20 0.32
▸ GABRA3 P34903 1/20 0.32
▸ GABRA2 P47869 1/20 0.32
▸ GABRB2 P47870 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30830557 0.92 KAT2B (0.38) DDB1CRBNSETDB1KAT2BBRD9
SCHEMBL30831022 0.92 KAT2B (0.38) DDB1CRBNSETDB1KAT2BBRD9
SCHEMBL30831103 0.89 KAT2B (0.42) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830850 0.84 KAT2B (0.53) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830914 0.84 KAT2B (0.53) KAT2BBRD9BRD1ACHEBRPF1
SCHEMBL30830799 0.83 KAT2B (0.41) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830566 0.81 KAT2B (0.38) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830510 0.81 KAT2B (0.34) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830534 0.80 KAT2B (0.37) DDB1CRBNKAT2BBRD9BRD1
SCHEMBL30830890 0.80 KAT2B (0.39) DDB1CRBNKAT2BBRD9BRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback